A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to have much of a premium. Sycamore is closing in on a deal for Walgreens ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Sycamore Partners is planning a three-way split of Walgreens Boots Alliance if a deal to take the struggling pharmacy chain ...

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare ...

A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports. | A rumored ...

PE firm Sycamore Partners reportedly plans to split Walgreens Boots Alliance into three independent businesses if it successfully acquires the drugstore chain.

What the telehealth prescribers can’t do, the compounders are. A major drug compounder association, the Outsourcing Facilities Association, along with member North American Custom Laboratories, LLC, ...

The private-equity suitor is planning on splitting up Walgreens' U.S. and U.K. pharmacy businesses, as well as its specialty ...

Sycamore Partners is eyeing a major Walgreens buyout--splitting the pharmacy giant into three. Will this rescue or wreck the ...